Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $113.01 billion. The enterprise value is $133.20 billion.
| Market Cap | 113.01B |
| Enterprise Value | 133.20B |
Important Dates
The next confirmed earnings date is Tuesday, November 19, 2024, before market open.
| Earnings Date | Nov 19, 2024 |
| Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -0.88% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | -2.18% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 85.14% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 29.68 and the forward PE ratio is 15.86. Medtronic's PEG ratio is 2.86.
| PE Ratio | 29.68 |
| Forward PE | 15.86 |
| PS Ratio | 3.57 |
| Forward PS | 3.31 |
| PB Ratio | 2.36 |
| P/FCF Ratio | 21.97 |
| PEG Ratio | 2.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.78, with an EV/FCF ratio of 25.89.
| EV / Earnings | 33.92 |
| EV / Sales | 4.09 |
| EV / EBITDA | 14.78 |
| EV / EBIT | 20.89 |
| EV / FCF | 25.89 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.13 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 5.42 |
| Interest Coverage | 8.64 |
Financial Efficiency
Return on equity (ROE) is 7.95% and return on invested capital (ROIC) is 5.23%.
| Return on Equity (ROE) | 7.95% |
| Return on Assets (ROA) | 4.41% |
| Return on Capital (ROIC) | 5.23% |
| Revenue Per Employee | $342,916 |
| Profits Per Employee | $41,337 |
| Employee Count | 95,000 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, Medtronic has paid $953.00 million in taxes.
| Income Tax | 953.00M |
| Effective Tax Rate | 19.42% |
Stock Price Statistics
The stock price has increased by +20.02% in the last 52 weeks. The beta is 0.85, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +20.02% |
| 50-Day Moving Average | 89.68 |
| 200-Day Moving Average | 84.48 |
| Relative Strength Index (RSI) | 41.60 |
| Average Volume (20 Days) | 5,162,240 |
Short Selling Information
The latest short interest is 10.77 million, so 0.84% of the outstanding shares have been sold short.
| Short Interest | 10.77M |
| Short Previous Month | 12.70M |
| Short % of Shares Out | 0.84% |
| Short % of Float | 0.84% |
| Short Ratio (days to cover) | 1.79 |
Income Statement
In the last 12 months, Medtronic had revenue of $32.58 billion and earned $3.93 billion in profits. Earnings per share was $2.97.
| Revenue | 32.58B |
| Gross Profit | 21.35B |
| Operating Income | 6.38B |
| Pretax Income | 4.81B |
| Net Income | 3.93B |
| EBITDA | 9.01B |
| EBIT | 6.38B |
| Earnings Per Share (EPS) | $2.97 |
Balance Sheet
The company has $7.84 billion in cash and $27.87 billion in debt, giving a net cash position of -$19.98 billion or -$15.58 per share.
| Cash & Cash Equivalents | 7.84B |
| Total Debt | 27.87B |
| Net Cash | -19.98B |
| Net Cash Per Share | -$15.58 |
| Equity (Book Value) | 48.16B |
| Book Value Per Share | 37.39 |
| Working Capital | 11.66B |
Cash Flow
In the last 12 months, operating cash flow was $6.90 billion and capital expenditures -$1.75 billion, giving a free cash flow of $5.15 billion.
| Operating Cash Flow | 6.90B |
| Capital Expenditures | -1.75B |
| Free Cash Flow | 5.15B |
| FCF Per Share | $4.01 |
Margins
Gross margin is 65.52%, with operating and profit margins of 19.57% and 12.05%.
| Gross Margin | 65.52% |
| Operating Margin | 19.57% |
| Pretax Margin | 15.07% |
| Profit Margin | 12.05% |
| EBITDA Margin | 27.67% |
| EBIT Margin | 19.57% |
| FCF Margin | 16.07% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.18%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.18% |
| Dividend Growth (YoY) | 1.46% |
| Years of Dividend Growth | 48 |
| Payout Ratio | 94.31% |
| Buyback Yield | 0.88% |
| Shareholder Yield | 4.06% |
| Earnings Yield | 3.47% |
| FCF Yield | 4.55% |
Analyst Forecast
The average price target for Medtronic is $94.07, which is 6.75% higher than the current price. The consensus rating is "Hold".
| Price Target | $94.07 |
| Price Target Difference | 6.75% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 4.85% |
| EPS Growth Forecast (5Y) | 22.00% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 5 |